COMPARISON OF NMP22 URINARY MARKER TEST AND URINE CYTOLOGY IN THE EARLY DETECTION OF RECURRENT TRANSITIONAL CELL CARCINOMA OF URINARY BLADDER

  • Dr. Abdul Rahman Abdul Mhdai
  • World Journal of Pharmacy and Pharmaceutical Sciences, September 2017, World Journal of Pharmacy and Pharmaceutical Sciences
  • DOI: 10.20959/wjpps20179-10064

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.20959/wjpps20179-10064